APPLICATION OF 3D PRINTING IN DENTISTRY- REVIEW
Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2019, Vol 6, Issue 11
Abstract
Over the past 30 years, 3D printing and prototyping has gained popularity within medical and dental profession and among patients alike. Three-dimensional (3D) printing is an additive manufacturing methods in which 3D objects are formed by laying layer by layer material. 3D printers are machines that produce representations of objects either planned with a CAD program or scanned with a 3D scanner. This review article highlights the history and current application of 3D printers in dentistry.
Authors and Affiliations
Dr. Jyoti Byakodi
OVARIAN CYSTIC LYMPHANGIOMAS: A CASE REPORT
Lymphangioma is a rare benign neoplasm of the lymphatic system comprised of multiple cystic spaces lined with endothelium. It may arise in any part of the body. Ovarian localisation is exceptional and only few cases have...
ISOLATION AND MOLECULAR IDENTIFICATION OF PATHOGENIC BACTERIA AND FUNGI FROM CLINICAL SAMPLES: COMPARATIVE INHIBITION BY ANTIBIOTICS
Hospital environment is the major cause of various infections including cut and burn wounds. Burn wounds are one of the most common and devastating forms of trauma, exposing the immune suppressed patients to early and se...
CASE REPORT ON PREAURICULAR CYST INFECTION
Preauricular cyst is a common congenital malformation and often asymptomatic but infection of the preauricular cysts can be presented with pain, inflammation, discharge and abscess formation. We report a case of infected...
RISK AND COST ANALYSIS OF INJECTABLE MEDICATIONS IN PEDIATRICS
RISK AND COST ANALYSIS OF INJECTABLE MEDICATIONS IN PEDIATRICS
NON–ST-ELEVATION MYOCARDIAL INFARCTION (NSTEMI) OUTCOMES IN TYPE 2 DIABETIC PATIENTS WITH NON-OBSTRUCTIVE CORONARY ARTERY STENOSIS: DIABETIC MYOCARDIAL INFARCTION CORONARY NON-OBSTRUCTIVE STENOSIS: DIA-MYCONOS STUDY.
Objective: Management of type 2 diabetic patients (DMT2) with non-obstructive coronary stenosis (NOCS) Non–ST-Elevation Myocardial Infarction (NSTEMI) is unclear. We evaluate the 12-month prognosis of DMT2 with NOCS-NSTE...